Africa RNA Vaccine Manufacturing Effort
Sector: Manufacturing (Industrial) • Location: Cairo, Egypt
Source: Genetic Engineering and Biotechnology News
Eva Pharma and partners are establishing a manufacturing system for RNA vaccines in Africa, aiming to produce 100 million doses annually by 2040. The project will utilize AI and automation to enhance production efficiency and ensure quality standards.
- Status
- Prospective
- Sector
- Manufacturing (Industrial)
- Location
- Cairo, Egypt
- Updated
- 22 Jul 2026
- Source
- Genetic Engineering and Biotechnology News
ConstructChat
Ask ConstructChat about Africa RNA Vaccine Manufacturing Effort
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | Planned |
Taiyo status | Prospective |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | Eva Pharma and partners are establishing a manufacturing system for RNA vaccines in Africa, aiming to produce 100 million doses annually by 2040. The project will utilize AI and automation to enhance production efficiency and ensure quality standards. |
Original sector | Biotechnology |
Location
Country | Egypt |
City | Cairo |
Source
Source | Genetic Engineering and Biotechnology News |
URL |
More Details
Record type | Project |
Sector | Manufacturing (Industrial) |
Article published date | 2025-03-07 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project